Gainers
- VYNE Therapeutics VYNE shares rose 87.0% to $0.36 during Monday's after-market session. At the close, VYNE Therapeutics's trading volume reached 2.9 million shares. This is 590.3% of its average volume over the last 100 days. The company's market cap stands at $20.8 million.
- Clearside Biomedical CLSD stock increased by 12.41% to $1.81. The market value of their outstanding shares is at $108.9 million.
- Nuwellis NUWE shares increased by 12.01% to $10.44. Nuwellis's trading volume hit 230.9K shares by close, accounting for 92.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.5 million.
- First Wave BioPharma FWBI shares increased by 7.69% to $0.98. First Wave BioPharma's trading volume hit 119.0K shares by close, accounting for 12.2% of its average volume over the last 100 days. The company's market cap stands at $5.6 million.
- Idera Pharmaceuticals IDRA shares increased by 6.14% to $0.71. The market value of their outstanding shares is at $44.2 million.
- Sutro Biopharma STRO shares moved upwards by 6.03% to $8.79. The market value of their outstanding shares is at $505.2 million.
Losers
- G Medical Innovations GMVD shares fell 12.3% to $3.86 during Monday's after-market session. At the close, G Medical Innovations's trading volume reached 113.4K shares. This is 266.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.8 million.
- Apexigen APGN shares decreased by 8.34% to $1.65. Today's trading volume for this security ended up closing at 8.3 million shares, which is 22539.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $37.2 million.
- Berkeley Lights BLI shares decreased by 7.93% to $2.44. The market value of their outstanding shares is at $168.0 million.
- Iterum Therapeutics ITRM shares fell 7.7% to $0.9. The company's market cap stands at $11.0 million.
- IsoPlexis ISO stock decreased by 7.65% to $1.45. The market value of their outstanding shares is at $58.4 million.
- Comera Life Sciences CMRA stock declined by 7.37% to $1.76. The company's market cap stands at $34.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in